Literature DB >> 31470253

Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.

Rita Citraro1, Michelangelo Iannone2, Antonio Leo1, Carmen De Caro1, Valentina Nesci1, Martina Tallarico3, Karim Abdalla4, Ernesto Palma1, Franco Arturi4, Giovambattista De Sarro1, Andrew Constanti5, Emilio Russo6.   

Abstract

Liraglutide (LIR) is a novel long-lasting glucagon-like peptide-1 (GLP-1) analogue that facilitates insulin signalling and shows also neuroprotective properties in different brain disease models. In this study, we explored the potential antiepileptogenic effects of LIR in two different animal models; namely, the mouse intrahippocampal kainic acid (KA) model of temporal lobe epilepsy and the WAG/Rij rat model of absence epileptogenesis. Moreover, we evaluated LIR effects on comorbidities in various behavioural tests. Mice with kainate-induced epilepsy were treated with LIR (300 μg/kg/day s.c.) for 4 weeks after status epilepticus and then evaluated for drug effects on seizure development and behavioural alterations, whereas WAG/Rij rats were treated for 17 weeks (starting at 30 days of age, before seizure onset) with LIR (300 μg/kg/day s.c.) in order to investigate whether an early chronic treatment was able to reduce the development of absence seizures and related comorbidities. Our results indicate that LIR was effective in reducing the development of spontaneous seizures in kainate-induced epilepsy; moreover, in this model, it prevented memory impairment and related anxiety-like behaviour in the open field (OF) test while in the forced swimming test (FST), LIR displayed an apparent pro-depressant effect that was instead related to reduced endurance as confirmed by rotarod test. In contrast, LIR was unable to modify the epileptogenic process underlying the development of absence seizures in WAG/Rij rats while being antidepressant in the FST in this strain. Our results indicate that LIR may represent a promising novel treatment to prevent and treat the epileptogenic process and its associated behavioural and cognitive alterations in some models of convulsive epilepsy characterized by neurodegeneration, since LIR effects are likely secondary to its recognised neuroprotective properties.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Epileptogenesis; GLP-1 receptor agonist; Kainate-induced seizures; Memory; WAG/Rij rats

Year:  2019        PMID: 31470253     DOI: 10.1016/j.brainresbull.2019.08.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy.

Authors:  Martina Tallarico; Antonio Leo; Lorenza Guarnieri; Maria Caterina Zito; Carmen De Caro; Ferdinando Nicoletti; Emilio Russo; Andrew Constanti; Giovambattista De Sarro; Rita Citraro
Journal:  Mol Neurobiol       Date:  2022-02-15       Impact factor: 5.590

2.  Disease Modification in Epilepsy: Behavioural Accompaniments.

Authors:  Emilio Russo; Rita Citraro
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 3.  Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders.

Authors:  Christian Hölscher
Journal:  Br J Pharmacol       Date:  2021-05-29       Impact factor: 8.739

4.  Liraglutide Is Protective against Brain Injury in Mice with Febrile Seizures by Inhibiting Inflammatory Factors.

Authors:  Xing Wang; Fei Yang; Liling Deng; Di Qiu; Yao Liu; Yang Kang
Journal:  Comput Math Methods Med       Date:  2022-04-29       Impact factor: 2.809

5.  Inhibition of adenosine A1 receptors abolished the nutritional ketosis-evoked delay in the onset of isoflurane-induced anesthesia in Wistar Albino Glaxo Rijswijk rats.

Authors:  Zsolt Kovács; Brigitta Brunner; Dominic P D'Agostino; Csilla Ari
Journal:  BMC Anesthesiol       Date:  2020-01-30       Impact factor: 2.217

6.  Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models.

Authors:  Csilla Ari; Cem Murdun; Craig Goldhagen; Andrew P Koutnik; Sahil R Bharwani; David M Diamond; Mark Kindy; Dominic P D'Agostino; Zsolt Kovacs
Journal:  Nutrients       Date:  2020-08-15       Impact factor: 5.717

7.  Effects of Postnatal Caffeine Exposure on Absence Epilepsy and Comorbid Depression: Results of a Study in WAG/Rij Rats.

Authors:  Gul Ilbay; Zeynep Ikbal Dogan; Aymen Balıkcı; Seyda Erdogan; Akfer Karaoglan Kahilogulları
Journal:  Brain Sci       Date:  2022-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.